Vascular system-peripheral veins, open approach

85816200 Category Share

Vascular system-peripheral veins, open approach is an EFRIS commodity class (code 85816200) under Administrative interventions or procedures, physiological systems and anatomical regions, introduction and irrigation and circulatory in Uganda Revenue Authority's e-invoicing system.

30 items in this category

• 85816210Introduction of analgesics, hypnotics, sedatives into peripheral vein, open approach
  Exempt
• 85816219Introduction of anti-inflammatory into peripheral vein, open approach
  Exempt
• 85816208Introduction of antiarrhythmic into peripheral vein, open approach
  Exempt
• 85816206Introduction of autologous pancreatic islet cells into peripheral vein, open approach
  Exempt
• 85816213Introduction of blood brain barrier disruption substance into peripheral vein, open approach
  Exempt
• 85816223Introduction of clofarabine into peripheral vein, open approach
  Exempt
• 85816207Introduction of destructive agent into peripheral vein, open approach
  Exempt
• 85816216Introduction of electrolytic and water balance substance into peripheral vein, open approach
  Exempt
• 85816227Introduction of high-dose interleukin-2 into peripheral vein, open approach
  Exempt
• 85816203Introduction of human b-type natriuretic peptide into peripheral vein, open approach
  Exempt
• 85816229Introduction of immunostimulator into peripheral vein, open approach
  Exempt
• 85816228Introduction of immunosuppressive into peripheral vein, open approach
  Exempt
• 85816204Introduction of insulin into peripheral vein, open approach
  Exempt
• 85816215Introduction of intracirculatory anesthetic into peripheral vein, open approach
  Exempt
• 85816226Introduction of low-dose interleukin-2 into peripheral vein, open approach
  Exempt
• 85816224Introduction of monoclonal antibody into peripheral vein, open approach
  Exempt
• 85816205Introduction of nonautologous pancreatic islet cells into peripheral vein, open approach
  Exempt
• 85816217Introduction of nutritional substance into peripheral vein, open approach
  Exempt
• 85816220Introduction of other anti-infective into peripheral vein, open approach
  Exempt
• 85816225Introduction of other antineoplastic into peripheral vein, open approach
  Exempt
• 85816211Introduction of other diagnostic substance into peripheral vein, open approach
  Exempt
• 85816202Introduction of other hormone into peripheral vein, open approach
  Exempt
• 85816214Introduction of other therapeutic substance into peripheral vein, open approach
  Exempt
• 85816222Introduction of other thrombolytic into peripheral vein, open approach
  Exempt
• 85816221Introduction of oxazolidinones into peripheral vein, open approach
  Exempt
• 85816209Introduction of platelet inhibitor into peripheral vein, open approach
  Exempt
• 85816212Introduction of radioactive substance into peripheral vein, open approach
  Exempt
• 85816230Introduction of recombinant human-activated protein c into peripheral vein, open approach
  Exempt
• 85816218Introduction of serum, toxoid and vaccine into peripheral vein, open approach
  Exempt
• 85816201Introduction of vasopressor into peripheral vein, open approach
  Exempt